These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 33146712)

  • 21. The active role of the transcription factor Sp1 in NFATc2-mediated gene regulation in pancreatic cancer.
    Malsy M; Graf B; Almstedt K
    BMC Biochem; 2019 Jan; 20(1):2. PubMed ID: 30696421
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Structural analysis of the cancer-specific promoter in mesothelin and in other genes overexpressed in cancers.
    Ren YR; Patel K; Paun BC; Kern SE
    J Biol Chem; 2011 Apr; 286(14):11960-9. PubMed ID: 21288909
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Protein Kinase Cι Drives a NOTCH3-dependent Stem-like Phenotype in Mutant KRAS Lung Adenocarcinoma.
    Ali SA; Justilien V; Jamieson L; Murray NR; Fields AP
    Cancer Cell; 2016 Mar; 29(3):367-378. PubMed ID: 26977885
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Targeting oncogenic protein kinase Cι for treatment of mutant KRAS LADC.
    Fields AP; Ali SA; Justilien V; Murray NR
    Small GTPases; 2017 Jan; 8(1):58-64. PubMed ID: 27245608
    [TBL] [Abstract][Full Text] [Related]  

  • 25. YAP1-mediated pancreatic stellate cell activation inhibits pancreatic cancer cell proliferation.
    Xiao Y; Zhang H; Ma Q; Huang R; Lu J; Liang X; Liu X; Zhang Z; Yu L; Pang J; Zhou L; Liu T; Wu H; Liang Z
    Cancer Lett; 2019 Oct; 462():51-60. PubMed ID: 31352078
    [TBL] [Abstract][Full Text] [Related]  

  • 26. HMGB1-RAGE signaling facilitates Ras-dependent Yap1 expression to drive colorectal cancer stemness and development.
    Qian F; Xiao J; Gai L; Zhu J
    Mol Carcinog; 2019 Apr; 58(4):500-510. PubMed ID: 30456802
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Protein kinase C iota regulates pancreatic acinar-to-ductal metaplasia.
    Scotti ML; Smith KE; Butler AM; Calcagno SR; Crawford HC; Leitges M; Fields AP; Murray NR
    PLoS One; 2012; 7(2):e30509. PubMed ID: 22359542
    [TBL] [Abstract][Full Text] [Related]  

  • 28. GNAS
    Ideno N; Yamaguchi H; Ghosh B; Gupta S; Okumura T; Steffen DJ; Fisher CG; Wood LD; Singhi AD; Nakamura M; Gutkind JS; Maitra A
    Gastroenterology; 2018 Nov; 155(5):1593-1607.e12. PubMed ID: 30142336
    [TBL] [Abstract][Full Text] [Related]  

  • 29. YAP1 oncogene is a context-specific driver for pancreatic ductal adenocarcinoma.
    Tu B; Yao J; Ferri-Borgogno S; Zhao J; Chen S; Wang Q; Yan L; Zhou X; Zhu C; Bang S; Chang Q; Bristow CA; Kang Y; Zheng H; Wang H; Fleming JB; Kim M; Heffernan TP; Draetta GF; Pan D; Maitra A; Yao W; Gupta S; Ying H
    JCI Insight; 2019 Nov; 4(21):. PubMed ID: 31557131
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Reversion of transcriptional repression of Sp1 by 5 aza-2' deoxycytidine restores TGF-beta type II receptor expression in the pancreatic cancer cell line MIA PaCa-2.
    Venkatasubbarao K; Ammanamanchi S; Brattain MG; Mimari D; Freeman JW
    Cancer Res; 2001 Aug; 61(16):6239-47. PubMed ID: 11507078
    [TBL] [Abstract][Full Text] [Related]  

  • 31. CpG methylation and transcription factors Sp1 and Sp3 regulate the expression of the human secretin receptor gene.
    Pang RT; Lee LT; Ng SS; Yung WH; Chow BK
    Mol Endocrinol; 2004 Feb; 18(2):471-83. PubMed ID: 14645499
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Molecular basis of the synergistic antiangiogenic activity of bevacizumab and mithramycin A.
    Jia Z; Zhang J; Wei D; Wang L; Yuan P; Le X; Li Q; Yao J; Xie K
    Cancer Res; 2007 May; 67(10):4878-85. PubMed ID: 17510417
    [TBL] [Abstract][Full Text] [Related]  

  • 33. An oncogenic KRAS transcription program activates the RHOGEF ARHGEF2 to mediate transformed phenotypes in pancreatic cancer.
    Kent OA; Sandí MJ; Burston HE; Brown KR; Rottapel R
    Oncotarget; 2017 Jan; 8(3):4484-4500. PubMed ID: 27835861
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Nicotine promotes initiation and progression of KRAS-induced pancreatic cancer via Gata6-dependent dedifferentiation of acinar cells in mice.
    Hermann PC; Sancho P; Cañamero M; Martinelli P; Madriles F; Michl P; Gress T; de Pascual R; Gandia L; Guerra C; Barbacid M; Wagner M; Vieira CR; Aicher A; Real FX; Sainz B; Heeschen C
    Gastroenterology; 2014 Nov; 147(5):1119-33.e4. PubMed ID: 25127677
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The LIM protein Ajuba/SP1 complex forms a feed forward loop to induce SP1 target genes and promote pancreatic cancer cell proliferation.
    Zhang B; Song L; Cai J; Li L; Xu H; Li M; Wang J; Shi M; Chen H; Jia H; Hou Z
    J Exp Clin Cancer Res; 2019 May; 38(1):205. PubMed ID: 31101117
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Ovatodiolide suppresses colon tumorigenesis and prevents polarization of M2 tumor-associated macrophages through YAP oncogenic pathways.
    Huang YJ; Yang CK; Wei PL; Huynh TT; Whang-Peng J; Meng TC; Hsiao M; Tzeng YM; Wu AT; Yen Y
    J Hematol Oncol; 2017 Feb; 10(1):60. PubMed ID: 28241877
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Calmodulin antagonists promote TRA-8 therapy of resistant pancreatic cancer.
    Yuan K; Yong S; Xu F; Zhou T; McDonald JM; Chen Y
    Oncotarget; 2015 Sep; 6(28):25308-19. PubMed ID: 26320171
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Mutant KRAS promotes liver metastasis of colorectal cancer, in part, by upregulating the MEK-Sp1-DNMT1-miR-137-YB-1-IGF-IR signaling pathway.
    Chu PC; Lin PC; Wu HY; Lin KT; Wu C; Bekaii-Saab T; Lin YJ; Lee CT; Lee JC; Chen CS
    Oncogene; 2018 Jun; 37(25):3440-3455. PubMed ID: 29559746
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Requirement of a specific Sp1 site for histone deacetylase-mediated repression of transforming growth factor beta Type II receptor expression in human pancreatic cancer cells.
    Zhao S; Venkatasubbarao K; Li S; Freeman JW
    Cancer Res; 2003 May; 63(10):2624-30. PubMed ID: 12750289
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The WW domains dictate isoform-specific regulation of YAP1 stability and pancreatic cancer cell malignancy.
    Guo Q; Quan M; Dong J; Bai J; Wang J; Han R; Wang W; Cai Y; Lv YQ; Chen Q; Xu H; Lyu HD; Deng L; Zhou D; Xiao X; De Langhe S; Billadeau DD; Lou Z; Zhang JS
    Theranostics; 2020; 10(10):4422-4436. PubMed ID: 32292505
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.